First report of ibrutinib in IgM-related amyloidosis: few responses, poor tolerability, and short survival - Pica, Tomas; Hegenbart, Ute; Maier, Bettina; Kimmich, Christoph; Schönland, Stefan (Blood, 2018)
First edition: November 27, 2017